in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – September 13
6:05 AM MDT | September 13, 2011 | Deepti Ramesh
EFCG RATIFIES FDA'S PROPOSED GENERIC DRUG USER FEES ACT The European Fine Chemicals Group (EFCG; Brussels) says its board has agreed to ratify the proposal of the U.S. Food and Drug Administration (FDA) to put forward a legislative package, designed with the help of EFCG and U.S. industry representatives, to deliver into U.S. law, a new generic drug user fees act (GDUFA). GDUFA requires the FDA to commit to significantly improve its regulatory activities for the benefit of global generic drug providers and U.S. generic drug users, in exchange for the global...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee